Back to search
FDAFDA · Food and drugs·Recall number Z-0277-2025

smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER

Published November 6, 2024 · Recall initiated: October 2, 2024

Summary

FDA records medical device Class II recall Z-0277-2025, published November 6, 2024 and initiated October 2, 2024. Recalling firm: Smith & Nephew Inc; Status: Ongoing; Reported quantity: 3 units; Lot: UDI/DI 03596010543820, Batch Number 23LM00479. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Smith & Nephew Inc
Distributor
US Distribution to state of Texas and OUS (foreign) to countries of: Spain, France and United Kingdom,.
Lot
UDI/DI 03596010543820, Batch Number 23LM00479
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER recalled?

Yes. FDA published recall Z-0277-2025 on November 6, 2024. Reported hazard: Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail